Summary: Several gene-based association tests for time-to-event traits have been proposed recently, to detect whether a gene region (containing multiple variants), as a set, is associated with the survival outcome. However, for bivariate survival outcomes, to the best of our knowledge, there is no statistical method that can be directly applied for gene-based association analysis. Motivated by a genetic study to discover gene regions associated with the progression of a bilateral eye disease, Age-related Macular Degeneration (AMD), we implement a novel functional regression method under the copula framework. Specifically, the effects of variants within a gene region are modeled through a functional linear model, which then contributes to the marginal survival functions within the copula.
Introduction
In genome-wide association studies (GWAS), single variant test is useful in detecting significant SNPs across the whole genome. Typically, after top loci are detected and confirmed in replication studies, regions around top variants will then be fine-mapped to further evaluate the disease loci. However, there are limitations of single variant tests. First, with each SNP been tested individually, it may suffer from issues such as lack of power and multiple testing adjustment. Secondly, the true causal SNP may not be genotyped due to the technology or cost reason. Instead, a SNP that is close to the true causal variant is often captured.
With partial linkage disequilibrium (LD), the observed effect size is likely to be smaller.
Furthermore, most statistical approaches used for single variant test focus on common variants and can be too liberal for rare variants with low minor allele frequency (MAF).
A threshold for MAF (e.g., 5%) is commonly applied when performing GWAS on single variants. To solve these problems, there has been increasing interests in developing genebased tests in genetic association analysis, which can usually take the LD information within a region into account and are suitable for collapsing a set of variants with low MAF.
The statistical methods for gene-based association studies can be broadly classified as burden tests, kernel-based association tests and functional-regression-based methods. Burden test was first proposed by Li and Leal (2008) for binary traits to detect association with rare variants for common diseases. The general idea of burden test is based on collapsing rare variants in a genetic region to a summary variable, which is then used for testing the association with the phenotype. Han and Pan (2010) extended the burden test to the censored time-to-event traits under Cox proportional hazards (PH) framework and Chien et al. (2017) further developed burden test for survival traits in family-based designs. Traditional burden test suffers from the lack of power when heterogeneous genetic effects exist within a region, therefore several adaptive approaches have been proposed recently. For example, Wu et al.
Method

Copula model for bivariate time-to-event data
One of the earliest distribution families for modeling correlated bivariate measurements is the copula family (Clayton 1978) , originated from Sklar's Theorem (Sklar 1959) , in which the joint distribution is modeled as a function of each marginal distribution together with a dependence parameter. Assume U and V are both uniformly distributed random variables, then a bivariate copula is a function defined as {C η : [0, 1] 2
The parameter η in the copula function describes the dependence between U and V .
By the Sklar's theorem (Sklar 1959) , one can model the joint distribution by modeling the dependence parameter and the marginal distributions separately. This is the unique feature of copula functions that makes them attractive to use. The theorem is stated as: if marginal survival functions S 1 (t 1 ) = P (T 1 > t 1 ) and S 2 (t 2 ) = P (T 2 > t 2 ) for T 1 and T 2 are continuous, then there exists a unique copula function C η such that for all t 1 0, t 2 0, the joint survival function S(t 1 , t 2 ) can be written as
Define the density function for C η to be c η = ∂ 2 C η (u, v)/∂ u∂ v, then the joint density function of T 1 and T 2 can be expressed as
In this work, we choose to use the Archimedean copula family, which is one of the most popular copula families because of its flexibility and simplicity. For example, the rankbased dependence measurement Kendall's τ can be directly obtained as a function of η in Archimedean copula models. Two most frequently used Archimedean copulas in survival analysis are:
Clayton copula (Clayton 1978 )
which models the lower tail dependence in survival functions; and Gumbel-Hougaard copula (Gumbel 1960 )
which models the upper tail dependence in survival functions.
We consider modeling the margins S 1 (·) and S 2 (·) inside the copula function using the Cox PH model, within which the effect of a gene region (captured by multiple single variants) is modeled through a FLM, as we describe below.
Functional Linear Model Specification
Assume n individuals with m variants being sequenced for a gene region. Physical positions for each variant within that region are denoted as 0 u 1 < · · · < u m (which are typically
. . , n, j = 1, . . . , m, denote the genotype information for the m variants of subject i, indicating the number of copies of the minor allele for each of these m variants. Let
denote a p × 2 matrix of bivariate covariates for subject i. Then the hazard function for the kth margin (k = 1, 2) under the PH-FLM can be written as
where λ k0 (t) is the baseline hazard function for the kth margin, β is a p × 1 vector of coefficients for the non-genetic covariates, and γ(u) is the genetic effect function of the genetic variant function G i (u) at position u. We assume both γ(u) and G i (u) are smooth functions. Then the corresponding marginal survival functions are
Next, we describe how we handle the two functions G i (u) and γ(u), respectively.
2.2.1
The genetic variant function (GVF) G i (u). If the genotype data are of good quality with low missing rate, we can simply use the observed genetic information to represent the
. In this case, the elements ofĜ i (u)
take discrete values 0, 1, 2.
If the genotype data have a fairly high missing rate or equivalent, the region has only a small number of variants being genotyped, one may consider applying an ordinary linear square smoother (Ramsay et al. 2009 ) to obtain a continuous realization of
) be a series of basis functions (e.g, B-spline or Fourier spline basis).
Denote by Φ the m × B G matrix with elements φ b (u j ), b = 1, . . . , B G , j = 1, . . . , m. Then through a linear square smoother, an estimate of the GVF can be written aŝ
Under the situation with missing data, we havê
where (g i (u 1 )), . . . , g i (u m )) are the observed non-missing genotypes andΦ is the corresponding basis matrix evaluated at the non-missing genotypes.
2.2.2
The genetic effect function (GEF) γ(u). The GEF γ(u) is an unknown smooth function with an arbitrary form that we need to estimate. To do this, one can approximate it using a sieve approach with a linear combination of basis functions and coefficients. Define a series of B γ basis function by ψ(u) = (ψ 1 (u), . . . , ψ Bγ (u)) and a B γ × 1 vector γ = (γ 1 , . . . , γ Bγ ) , then γ(u) can be approximated bŷ
To test whether the variants in a region, as a set, is associated with the outcome, it is to test whether the GEF is a zero function γ(u) = 0, which is equivalent to test the null hypothesis:
Typically, the number of basis B γ is much smaller than the number of variants m in the region being tested.
2.2.3
The hazard function λ(t) under the FLM. Depending on whether or not to smooth the GVF G(u), we propose two types of functional regression models for the hazard function.
The first option is to smooth both G(u) and γ(u). By replacing G(u) and γ(u) with their approximated values in (2.2) and (2.3), the hazard function for each margin can be written
where Another option is to smooth γ(u) only. In this case, we directly replace G i (u) by the
) and replace γ(u) by (2.3), which yields
where
) is a fully observed term. Fourier splines consist of a set of periodic functions, with the basis function being Φ 1 (u) = 1, Φ 2r (u) = cos(2πru) and Φ 2r+1 (u) = sin(2πru) for a pre-specified r (de Boor 2011).
Bivariate FLM under the copula framework
Let (T 1i , T 2i ) and (C 1i , C 2i ) denote the bivariate survival times and censoring times for subject i, respectively. Denote by ∆ i = (∆ 1i , ∆ 2i ) the corresponding censoring indicator. We consider right censoring and assume that given covariates, (T 1 , T 2 ) and (C 1 , C 2 ) are independent. Then for each subject, we observe
Denote by θ all the parameters in S(t 1 , t 2 ), then the joint likelihood for the observed data
can be written as
where (δ 1i , δ 2i ) ∈ {(0, 0), (0, 1), (1, 0), (1, 1)}. Then under the copula framework (2.1), with a FLM for the genetic effect, the joint survival function can be further written as
where λ ki (t) can be modeled by either (2.4) or (2.5), depending whether to smooth the GVF
2.3.1 Generalized score test. We are interested in testing whether a gene region is associated with the disease progression, after adjusting for other risk factors. To accomplish this, we separate the entire parameter θ into two parts: θ 1 , the parameter of interest; and θ 2 , the nuisance parameter. Under the bivariate FLM-based copula model, we have θ 1 = γ, which is the gene/region effect, and θ 2 = (β, η, λ 10 , λ 20 ) contains the rest of parameters in the likelihood. Then the null hypothesis can be formulated as
In GWAS, score test is typically preferred than other likelihood-based tests due to its computational advantage. This is because only one null model (without any SNP) needs to be fitted for the score test. We now describe the generalized score test under the FLM-based copula framework for testing (2.7).
of θ under the restriction of θ 1 = 0, solved from the joint likelihood under (2.6), then the corresponding score function is
where U l (·) = ∂ log L/∂θ l , l = 1, 2, and the Fisher's information is
with I 11 , I 12 , I 21 and I 22 being partitions of the information matrix I by θ 1 and θ 2 .
Finally, by using the observed information matrix
) to approximate I(θ 0 ), the generalized score statistic for testing (2.7) can be constructed as follows
where U 1 (θ 0 ) is a B γ × 1 vector and
We can use similar numerical approximation techniques as proposed in Sun et al. (2019) 
where L(θ) is the the unrestricted maximum likelihood value of the joint likelihood and L(θ 0 ) is the restricted maximum likelihood under H 0 . Q l also asymptotically follows a χ 2 distribution with degrees of freedom B γ .
Simulation Study
In this section, we performed simulation studies to evaluate the performance of the proposed method in terms of type-I error control and power. Two scenarios were considered: (1) 
Data generation
In our simulation, 100 genotype datasets, each with a sample size 1000 were simulated.
For each genotype set, 1000 phenotype datasets of bivariate survival times and one nongenetic covariate were generated, which lead to a total of 100,000 datasets. Similar simulation approach was used in Chen et al. (2014) , which has been shown to produce valid comparisons between methods.
Genetic data were generated from European ancestry of 10,000 haplotypes covering 1Mb
regions, simulated by Yun Li at the University of North Carolina (Fan et al. 2016 ). Calibrated coalescent model as programmed in COSI was used to generate the haplotypes with linkage disequilibrium (LD) information (Schaffner et al. 2005) . With 10,000 haplotypes, we chose a genetic region of length 6 Kb and 30 Kb for all and rare only variants scenarios, respectively.
For both scenarios, the regions contain around 20 variants. A random mating technical was then applied to generate genetic information for 1000 subjects.
Bivariate time-to-event phenotypes were generated from a Clayton Weibull model as follows. Recall that under a copula model respectively. The scale and shape parameters in the baseline Weibull distribution were set to be λ = 0.1 and k = 2, same for both margins. For Clayton copula, the dependence strength is determined by Kendall's τ . Here we chose τ = 0.05, 0.4 and 0.8 to represent weak to strong dependence between two marginal survivals. Censoring times c 1i and c 2i were generated from uniform distribution U (0, C) with C chosen to yield a 50% censoring rate. The non-genetic covariate X ng,k (k = 1, 2) was generated from N (6, 2 2 ).
For type-I error control simulations, we assumed there is neither a genetic effect (γ(u) = 0) nor a non-genetic effect (β = 0). The type-I error was evaluated at various α levels:
0.05, 0.01, 10 −3 and 10 −4 , respectively. For power analysis, we generated data to evaluate both homogeneous genetic effects (genes with effects in the same direction) and heterogeneous genetic effects (genes with effects in opposite directions). Similar as in (Fan et al. 2016 ), the effect size for each causal variant (i.e., γ(u)) was chosen to be a constant that depends on MAF: c
, where c = 0.4, 0.3, 0.25 for scenarios with 10%, 20% and 30% of causal variants in a given region, respectively.
Type-I error
We chose B-splines with 5 basis for all FLM methods. Table 1 [ [ Table 2 for the mixture of common and rare variants scenario. Given the independent Cox model cannot control type-I error at all, we did not include it in the power analysis. Overall, the bivariate approaches produce higher power than any univariate approach. When the two margins are highly dependent, the copula-based tests achieve higher power than the CoxRst method. In general, the score and LRT tests provide similar results, which is as expected.
We also notice that, when there are heterogeneous genetic effects in a region (the bottom panel), the power of burden test drops significantly. Figure 2 shows the power analysis for the rare variants only scenario. It can be seen that when only rare variants are considered, the univariate Cox FLM model (CoxFLM) does not perform well as compared to other univariate methods, which is different from the case when all variants are included. In contrast, SKAT maintains relatively high power for both cases of homogeneous and heterogeneous genetic effects. Burden test shows comparable results when the genetic effects are homogeneous, and the power drops when the effects are heterogeneous.
As for the bivariate methods, Cox-Rst model performs well when the dependence between two margins is weak, but as the dependence increases, the power tends to decrease. Overall, our copula-based bivariate methods achieve high power in all the scenarios.
[ Figure 2 about here.]
Application on AREDS data
Examination on the Reported Four Regions from Previous Publications
AREDS is a major clinical trial sponsored by the National Eye Institute to study the risk factors for AMD progression (Age-Related Eye Disease Study Research Group 1999). The bilateral nature makes it a perfect example for the demonstration of our proposed methods.
Over the past few years, many case-control GWAS studies have identified multiple SNPs associated with AMD susceptibility (Chen et al. 2010; Fritsche et al. 2013 Fritsche et al. , 2016 and recent genetic studies on AMD progression identified SNPs that are associated with disease progression (Ding et al. 2017; Yan et al. 2018) . Table 3 presents top four genetic regions which contain SNPs associated with AMD risk identified by the traditional single-marker GWAS in Fritsche et al. (2016) . These four regions were also reported to be top gene regions containing variants associated with AMD progression in Yan et al. (2018) . Therefore, we first examined these four candidate regions specifically. Location of gene regions were extracted based on GRCh37/hg19 assembly from UCSC Genome Browser. Variants within +/ − 5Kb of the region boundary were included in the analysis.
We included all Caucasian participants with neither eye progressed at the time of enrollment into the study. For bivariate approaches, time-to-progression was calculated for each eye of each patient. For univariate approaches, only left-eye data were used. A total of 2296 subjects were included in the analysis. The baseline age and disease severity score (on a continuous scale ranging from 1 to 8) were included in the regression part of the model as the non-genetic risk factors.
[ Table 3 about here.]
We fitted a Clayton copula with Weibull margins to perform the gene-based analysis. Bspline was used to smooth the genetic effect function. The number of basis is usually decided based upon the sample size (or equivalently, the total number of events in survival analysis)
or through cross validations. In our analysis, we examined three different number of bases:
5, 6 and 7. A mixture of common (MAF> 5%) and rare causal variants (MAF∈ [1%, 5%])
were tested. Similar to the simulation studies, we compared our proposed copula-based FLM score test to the Cox robust model, the univariate Cox FLM, SKAT and burden test. Since the copula-based FLM LRT has shown virtually identical results to the score test in the simulations, we did not include it here. Table 4 ARMS2 and C2 regions both show reasonable amount of effects and thus the copula-based FLM method has detected these two regions to be significant. The flat curve presented by the C3 region also explains the marginal significance from the copula-FLM approach.
[ Table 4 about here.]
[ Figure 3 about here.]
Genome-wide Association Study
We then applied the copula-based model on the whole genome to search for top gene regions that are associated with the AMD progression. Again, all gene regions were extracted based on GRCh37/hg19 assembly from UCSC Genome Browser and those with less than 10 SNPs were excluded from the analysis. In total we analyzed 22,747 gene regions. Table 5 (Goverdhan et al. 2005) .
[ Table 5 about here.]
Conclusion and Discussion
In this work, we have developed a new gene-based association analysis method for bivariate time-to-event data using the functional linear model under the copula framework. We Extensive simulation studies were performed to evaluate the type-I error rates and power performance of our method. Both the score test and the LRT from our copula FLM model control type-I error well. For the power analysis, our bivariate tests show great advantage by utilizing all available data without collapsing them into the subject level.
We successfully applied our method on AREDS data at four known AMD risk gene regions and obtained consistent findings. Through the genome-wide study, nine gene regions were found to be significantly associated with the disease progression, where PCDH9-AS4, DLGAP2-AS1, LINC00476, GABRA5, CLEC4GP1, HLA-C and SULF1 are novel regions.
The findings from this research provide new perspectives on the genetic underpinning of AMD progression, which will be valuable to establish novel and reliable predictive models for AMD progression. The proposed method is useful for genome-wide association studies of any bilateral disease with survival traits to identify disease susceptible gene regions. 
